Key result
High serum levels of ANGPTL7 were associated with a significantly increased risk of 30-day mortality (OR 6.77; 95% CI 1.41-32.61; p=0.017) and 90-day mortality in patients with acute heart failure.
Why the study?
The prognostic utility of angiopoietin-like protein 7 (ANGPTL7) among patients with acute heart failure remains unclear.
Is high serum ANGPTL7 associated with increased short-term mortality in patients with acute heart failure?
Cohort (n=142)
Is high serum ANGPTL7 associated with increased short-term mortality in patients with acute heart failure?
Elevated serum ANGPTL7 levels are independently associated with increased 30- and 90-day mortality in patients with acute heart failure, suggesting its potential as a prognostic biomarker.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for ANGPTL7 in acute heart failure prognostication; requires prospective validation before clinical adoption.
INTRODUCTION: Angiopoietin-like protein 7 (ANGPTL7) is involved in extracellular matrix expression and inflammatory responses. However, the prognostic utility of ANGPTL7 among patients with acute heart failure (AHF) remains unclear. OBJECTIVE: To evaluate the association between ANGPTL7 and short-term mortality due to AHF. METHODS AND RESULTS: Patients with AHF were prospectively studied. Serum levels of ANGPTL7 were measured by an enzyme-linked immunosorbent assay. Associations between 30- and 90-day mortality and tertiles of ANGPTL7 were assessed by multivariate logistic regression models. The study comprised 142 patients. Median patient age was 68 years, and 69.7% were male. There were 20 deaths within 30 days and 37 deaths within 90 days. Crude rates of 30-day mortality in low, intermediate, and high tertiles of ANGPTL7 were 4.6, 14.6, and 22.9%, respectively. Crude rates of 90-day mortality of corresponding tertiles were 15.2, 25.0, and 37.5%. After adjusting for potential confounders, including NT-proBNP, the high tertile of ANGPTL7 was associated with a significantly increased risk of both 30-day mortality (odds ratio [OR]: 6.77, 95% confidence interval [CI]: 1.41-32.61, p = 0.017) and 90-day mortality (OR: 3.78, 95% CI: 1.38-10.36, p = 0.010) compared with the low tertile of ANGPTL7. Although mortality risk tended to be higher in the intermediate tertile than the low tertile, it did not reach statistical significance (OR: 3.75, 95% CI: 0.73-19.14, p = 0.113 for 30-day mortality; OR: 1.88, 95% CI: 0.66-5.34, p = 0.236 for 90-day mortality). CONCLUSIONS: Serum level of ANGPTL7 was independently associated with short-term mortality among patients with AHF.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2020) conducted a cohort in Acute heart failure (n=142). High tertile of ANGPTL7 vs. Low tertile of ANGPTL7 was evaluated on 30-day mortality (OR 6.77, 95% CI 1.41-32.61, p=0.017). High serum levels of ANGPTL7 were associated with a significantly increased risk of 30-day mortality (OR 6.77; 95% CI 1.41-32.61; p=0.017) and 90-day mortality in patients with acute heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: